Nominal Sponsor
Overview
This educational activity will focus on the main aspects of ART The program will start with the low prognosis patients, focusing on the diagnostic assessment of the condition and its management.; then, the lectures will be focused on the management of other aspects of ART treatment, defining the clinical applicability through the real-world data availability .
The program will take place in Asia Pacific and Europe and will engage renowned international and regional experts with vast clinical experience in constantly evolving subjects.
Learning Objectives
After attending the educational activities, learners will be able to:
- • Define severe LH and FSH deficiency and patient management.
- • Individualize and manage women with expected or unexpected prognosis to ART as per the POSEIDON classification.
- • Learn more about different ovulation trigger possibilities
- • Redefine PCO and management strategies.
- • Evaluate luteal phase supplementations in fresh and frozen cycles.
- • Estimate pregnancy outcomes in the freeze-all strategy.
Target Audience
The program is intended for clinicians, embryologists, andrologists, scientists, and managers working in ART who wish to update their knowledge of advanced techniques and scientific innovations and understand best practices using evidence-based models of care.
Accreditation
The “Improve the chances of a successful pregnancy Workshop” has been submitted for CME accreditation to the European Accreditation Council for Continuing Medical Education (EACCME).
The content of the “Improve the chances of a successful pregancy Workshop – 1st Workshop 15 April 2023 SINGAPORE” has been certified by the CPD Certification Service as conforming to continuing professional development principles

Language
The official language of the activity will be English
Partnership
*Association of Reproductive Medicine and Surgery (ARMS)
POSEIDON – Patient Oriented Strategies Encompassing IndividualizeD Oocyte Number
Algerian Society of Reproductive Medicine (SAMERE)
Brazilian Association of Assisted Reproduction (SBRA)
Spanish Fertility Society (SEF)
Italian Society of Fertility and Sterility (SIFES)
Previous
Next
Improve the chances of a successful pregnancy
Hybrid Workshop
Asia Pacific
1st workshop: 15 April 2023 Singapore, Republic of Singapore
2nd Workshop: Venue and date to be announced
Chairs
International Committee
Habib Midassi
IVF Center Polyclinic Ibn Annafis
Sfax, Tunisia
Fertility Group of the STGO (Tunisian Society of obstetrics and gynecology)
Sfax, Tunisia
Biography
Sfax, Tunisia
Fertility Group of the STGO (Tunisian Society of obstetrics and gynecology)
Sfax, Tunisia
Faculty
1st Workshop
15 April 2023
Save the date
Scientific program
Saturday, 15 April 2023
Date and venue to be announced
Saturday, 15 April 2023
From 09.00 to 16.20
Singapore Time (SGT)
Agenda: Singapore Time (SGT)
09.00 MedEA Welcome and introduction
Robert Fischer, Germany
09.05 Local welcome
PC Wong, Singapore
09.10 Workshop introduction
Carlo Alviggi, Italy
09.15 L1 – Low prognosis patient’s introduction to the POSEIDON criteria
Robert Fischer, Germany
09.40 L2 -Management strategies in POSEIDON group 1 and 2 patients
Carlo Alviggi, Italy
10.05 L3 – Management strategies in POSEIDON group 3 and 4 patients
Robert Fischer; Germany
10.30 Discussion
11.00 Coffee break
11.20 L4 – Managing a good prognosis patient
Andrew Kan, Australia
11.45 L5 – Defining severe LH and FSH deficiency and patients management
Zhongwei Huang, Singapore
12.00 L6 – Duo Stim to Optimize Number of Oocytes and Time to pregnancy in Low Prognosis Patients
Carlo Alviggi, Italy
12.25 Discussion
13.00 Lunch
14.00 L7 – Luteal phase supplementations in fresh and frozen cycles
Su Ling Yu, Singapore
Su Ling Yu, Singapore
14.25 L8 – L8 – Redefining PCOS and management strategies
Andrew Kan, Australia
14.50 Discussion
15.10 Coffee break
15.30 L9 – Freeze all strategy – for all patients?
Zhongwei Huang, Singapore
15.55 Discussion
16.20 Closing remarks
Robert Fischer, Carlo Alviggi, PC Wong
Date and venue to be announced
From 09.00 to 18.00 Central European Time (CET)
Agenda: CET Central Europe Time
- Low prognosis patient’s introduction to the POSEIDON criteria
- Management strategies in POSEIDON group 1 and 2 patients
- Management strategies in POSEIDON group 3 and 4 patients
- Managing a good prognosis patient
- Defining severe LH and FSH deficiency and patients management
- Ovulation trigger options in ART
- Luteal phase supplementations in fresh and frozen cycles
- Redefining PCO and management strategies
- Freeze all strategy – for all patients?
- Evidence-based medicine what is acceptable.
Registration
Onsite Registration:
CLICK ABOVE for registration, accommodation and any logistic inquiry.
Standard registration fee: 200.00€
Reduced fees for members of affiliated Scientific Societies*: 150.00€
Reduced fees: 100.00€ for residents and fellows in training.
The registration includes:
• Scientific sessions
• Coffee breaks and lunch
• Educational materials
• Certificate of attendance
* Association of Reproductive Medicine and Surgery (ARMS); POSEIDON – Patient Oriented Strategies Encompassing IndividualizeD Oocyte Number; Algerian Society of Reproductive Medicine (SAMERE); Brazilian Association of Assisted Reproduction (SBRA); Spanish Fertility Society (SEF); Italian Society of Fertility and Sterility (SIFES); Portuguese Society of Reproductive Medicine (SPMR); Tunisian Society of Gynecology and Obstetrics (STGO)